Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest
Display:
?
Cancer Type/Condition:  Eye cancer, intraocular melanoma
Stage/Subtype:  ciliary body and choroid melanoma, medium/large size
Country:  U.S.A.
Trial Type:  Treatment
Results 1-6 of 6 for your search:
Start Over
Yttrium Y 90 Resin Microspheres in Treating Patients With Uveal Melanoma Who Have Liver Metastases
Status: Active
Phase: Phase II
Type: Treatment
Age: 18 and over
Trial IDs: 10C.95, NCI-2012-00140, 2010-02, NCT01473004
Sunitinib Malate or Valproic Acid in Preventing Metastasis in Patients With High-Risk Uveal Melanoma
Status: Active
Phase: Phase II
Type: Treatment
Age: 18 and over
Trial IDs: 13P.377, NCI-2014-00338, 2013-047, NCT02068586
Crizotinib following Surgery or Radiation Therapy in Treating Patients with High-Risk Uveal Melanoma
Status: Active
Phase: Phase II
Type: Treatment
Age: 18 and over
Trial IDs: 14-063, NCI-2014-01895, NCI-2015-00689, NCT02223819
Glembatumumab Vedotin in Treating Patients with Metastatic or Locally Recurrent Uveal Melanoma
Status: Temporarily closed
Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: 9855, NCI-2015-00159, NCI9855, NCT02363283
Selumetinib Sulfate in Treating Patients with Uveal Melanoma That Is Metastatic or Cannot Be Removed by Surgery
Status: Active
Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: AAAQ6999, NCI-2016-01205, NCT02768766
Pembrolizumab and Stereotactic Radiosurgery in Treating Patients with Melanoma or Non-small Cell Lung Cancer That Has Spread to the Brain
Status: Active
Phase: No phase specified
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: RAD3179-16, NCI-2016-00718, IRB00086461, NCT02858869
Start Over